Bone Microcirculation After Remote Ischemic Preconditioning
Effects of Remote Ischemic Preconditioning in Bone Microcirculation
1 other identifier
interventional
80
1 country
1
Brief Summary
In trauma surgery and hand surgery treatment strategies of none healing bone fractures aim at replacing pseudarthrosis by well vascularized bone and improving microcirculation. Although previous studies indicate that remote ischemic preconditioning (RIPC) can accelerate bone healing in case of non-union, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of remote ischemic preconditioning (RIPC) on scaphoid bones and metacarpal bones and metatarsal bones in a human in-vivo setting for the first time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 16, 2015
CompletedFirst Posted
Study publicly available on registry
September 18, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedFebruary 24, 2023
February 1, 2023
7.4 years
September 16, 2015
February 22, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in microcirculation (composite outcome measure)
* Bone blood flow \[arbitrary units AU\] * Bone blood velocity \[AU\] * Tissue oxygen saturation \[%\] * Relative postcapillary venous filling pressure \[AU\] (Composite outcome measure)
Baseline and 1 minute post-dose
Study Arms (5)
Intact scaphoid bone
EXPERIMENTALGroup A (n=20): Consent-capable male and female patients ≥18 years of age who have an intact scaphoid bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Intact metacarpal bone
EXPERIMENTALGroup B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metacarpal bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Fractured scaphoid bone
EXPERIMENTALGroup C (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured scaphoid bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Fractured metacarpal bone
EXPERIMENTALGroup D (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured metacarpal bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Intact metatarsal bone
EXPERIMENTALGroup B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metatarsal bone. Intervention: Remote Ischemic Preconditioning (by Blood Pressure Cuff)
Interventions
Remote Ischemik Preconditioning is performed using a Blood Pressure Cuff with a pressure slightly above patients' blood pressure on the upper arm.
Eligibility Criteria
You may qualify if:
- Group A (n=20): Consent-capable male and female patients ≥18 years of age who have an intact scaphoid bone.
- Group B (n=20): Consent-capable male and female patients ≥18 years of age who have an intact metacarpal bone.
- Group C (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured scaphoid bone.
- Group D (n=20): Consent-capable male and female patients ≥18 years of age who have a fractured metacarpal bone.
You may not qualify if:
- below 18 years of age
- scar tissue above measuring focus
- osteoporosis or comparable bone disease
- medication that influences bones
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Schleswig-Holstein
Lübeck, Schleswig-Holstein, 23538, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Tobias Kisch, MD
University Hospital Schleswig-Holstein
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
September 16, 2015
First Posted
September 18, 2015
Study Start
September 1, 2015
Primary Completion
February 1, 2023
Study Completion
February 1, 2023
Last Updated
February 24, 2023
Record last verified: 2023-02